Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Pronounced tumour regression after radiotherapy is associated with negative/weak glucose transporter-1 expression in rectal cancer.

Korkeila E, Jaakkola PM, Syrjänen K, Pyrhönen S, Sundström J.

Anticancer Res. 2011 Jan;31(1):311-5.

PMID:
21273616
[PubMed - indexed for MEDLINE]
2.

GLUT-1 expression and response to chemoradiotherapy in rectal cancer.

Brophy S, Sheehan KM, McNamara DA, Deasy J, Bouchier-Hayes DJ, Kay EW.

Int J Cancer. 2009 Dec 15;125(12):2778-82. doi: 10.1002/ijc.24693.

PMID:
19569052
[PubMed - indexed for MEDLINE]
3.

p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.

Saw RP, Morgan M, Koorey D, Painter D, Findlay M, Stevens G, Clarke S, Chapuis P, Solomon MJ.

Dis Colon Rectum. 2003 Feb;46(2):192-202.

PMID:
12576893
[PubMed - indexed for MEDLINE]
4.

Pretreatment HIF-1α and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer.

Havelund BM, Sørensen FB, Lindebjerg J, Spindler KL, Jakobsen A.

Anticancer Res. 2011 May;31(5):1559-65.

PMID:
21617210
[PubMed - indexed for MEDLINE]
5.

Preoperative radiotherapy modulates ezrin expression and its value as a predictive marker in patients with rectal cancer.

Korkeila EA, Syrjänen K, Bendardaf R, Laulajainen M, Carpén O, Pyrhönen S, Sundström J.

Hum Pathol. 2011 Mar;42(3):384-92. doi: 10.1016/j.humpath.2010.08.004. Epub 2010 Dec 28.

PMID:
21190723
[PubMed - indexed for MEDLINE]
6.

Predictors of tumor response after preoperative chemoradiotherapy for rectal adenocarcinomas.

Guedj N, Bretagnol F, Rautou PE, Deschamps L, Cazals-Hatem D, Bedossa P, Panis Y, Couvelard A.

Hum Pathol. 2011 Nov;42(11):1702-9. doi: 10.1016/j.humpath.2011.01.015. Epub 2011 Apr 29.

PMID:
21531003
[PubMed - indexed for MEDLINE]
7.

Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer.

Nagtegaal ID, Marijnen CA, Kranenbarg EK, Mulder-Stapel A, Hermans J, van de Velde CJ, van Krieken JH; Pathology Review Committee.

J Pathol. 2002 May;197(1):20-7.

PMID:
12081199
[PubMed - indexed for MEDLINE]
9.

Clinicopathological significance and linkage of the distribution of HIF-1alpha and GLUT-1 in human primary colorectal cancer.

Wincewicz A, Sulkowska M, Koda M, Sulkowski S.

Pathol Oncol Res. 2007;13(1):15-20. Epub 2007 Mar 27.

PMID:
17387384
[PubMed - indexed for MEDLINE]
Free Article
10.

Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy.

Grillo-Ruggieri F, Mantello G, Berardi R, Cardinali M, Fenu F, Iovini G, Montisci M, Fabbietti L, Marmorale C, Guerrieri M, Saba V, Bearzi I, Mattioli R, Bonsignori M, Cascinu S.

Dis Colon Rectum. 2007 Oct;50(10):1594-603.

PMID:
17846841
[PubMed - indexed for MEDLINE]
11.

Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma.

Vironen J, Juhola M, Kairaluoma M, Jantunen I, Kellokumpu I.

Int J Colorectal Dis. 2005 Sep;20(5):440-5. Epub 2005 Apr 23.

PMID:
15856263
[PubMed - indexed for MEDLINE]
12.

Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.

Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C.

J Clin Oncol. 2006 Sep 1;24(25):4062-8.

PMID:
16943523
[PubMed - indexed for MEDLINE]
Free Article
13.

Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer.

Korkolis DP, Plataniotis GD, Gondikakis E, Xinopoulos D, Koulaxouzidis GV, Katsilieris J, Vassilopoulos PP.

Int J Colorectal Dis. 2006 Jan;21(1):1-6. Epub 2005 Jun 10.

PMID:
15947936
[PubMed - indexed for MEDLINE]
14.

Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.

Saigusa S, Tanaka K, Toiyama Y, Yokoe T, Okugawa Y, Ioue Y, Miki C, Kusunoki M.

Ann Surg Oncol. 2009 Dec;16(12):3488-98. doi: 10.1245/s10434-009-0617-z.

PMID:
19657699
[PubMed - indexed for MEDLINE]
15.

Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer.

Wang Q, Chen ZG, Du CZ, Wang HW, Yan L, Gu J.

Histopathology. 2009 Sep;55(3):284-93. doi: 10.1111/j.1365-2559.2009.03378.x.

PMID:
19723143
[PubMed - indexed for MEDLINE]
16.

[Morphologic changes in cancer of the rectum under the influence of preoperative radiotherapy].

Smirnov IM, Simbirtseva LP, Sneskho LI.

Vopr Onkol. 1973;19(6):49-56. Russian. No abstract available.

PMID:
4360328
[PubMed - indexed for MEDLINE]
17.

The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer.

Perez RO, São Julião GP, Habr-Gama A, Kiss D, Proscurshim I, Campos FG, Gama-Rodrigues JJ, Cecconello I.

Dis Colon Rectum. 2009 Jun;52(6):1137-43. doi: 10.1007/DCR.0b013e31819ef76b.

PMID:
19581858
[PubMed - indexed for MEDLINE]
18.

Combined modality therapy in low risk (T2N0) rectal cancer.

Coco C, Magistrelli P, Netri G, Cogliandolo S, Carbone L, Morganti AG, Ziccarelli L, Valentini V.

Rays. 1995 Apr-Jun;20(2):156-64. English, Italian.

PMID:
7480864
[PubMed - indexed for MEDLINE]
19.

Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.

Bertolini F, Bengala C, Losi L, Pagano M, Iachetta F, Dealis C, Jovic G, Depenni R, Zironi S, Falchi AM, Luppi G, Conte PF.

Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1455-61. Epub 2007 Apr 18.

PMID:
17445998
[PubMed - indexed for MEDLINE]
20.

Impact of colloid response on survival after preoperative radiotherapy in locally advanced rectal carcinoma.

Rullier A, Laurent C, Vendrely V, Le Bail B, Bioulac-Sage P, Rullier E.

Am J Surg Pathol. 2005 May;29(5):602-6.

PMID:
15832083
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk